From: Observational studies - should we simply ignore them in assessing transfusion outcomes?
 | Studies analyzed listed by first author | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Confounder | Carson | Corwin | Croce | Dunne | Gong | Janson | Koch | Malone | Rao | Silver-board | Vincent | Yang | Total |
Cardio-vascular comorbidities | 6 | Â | 1 | Â | 1 | Â | 9 | Â | 13 | Â | Â | 13 | 43 |
Demographic/Socio-economic factors | 5 | Â | 2 | 3 | 3 | 2 | 3 | 3 | 4 | 2 | 1 | 5 | 33 |
Severity of disease scores | 3 | Â | 3 | 2 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | Â | 18 |
Other admission adjustments | 6 | Â | Â | Â | 3 | 1 | Â | Â | 1 | 1 | Â | Â | 12 |
Perioperative adjustments | 3 | Â | Â | Â | Â | 3 | 5 | Â | Â | Â | Â | Â | 11 |
Tests and procedure results | 1 | Â | 1 | Â | 3 | Â | 2 | 2 | 1 | Â | Â | Â | 10 |
Hemoglobin/Hematocrit | 2 | 2 | Â | Â | Â | Â | 1 | 1 | 1 | Â | 1 | Â | 8 |
Diabetes | Â | Â | Â | Â | 1 | Â | 2 | Â | 1 | Â | Â | 1 | 5 |
Alcohol/Tobacco use | 1 | Â | Â | Â | 2 | Â | 2 | Â | Â | Â | Â | Â | 5 |
Medication | 1 | Â | Â | Â | 1 | Â | Â | Â | 3 | Â | Â | Â | 5 |
Renal comorbidities | Â | Â | Â | Â | 1 | Â | 1 | Â | 1 | Â | Â | 1 | 4 |
Smoking status | Â | Â | Â | Â | Â | Â | Â | Â | 1 | Â | Â | 1 | 2 |
Blood loss | 1 | Â | Â | Â | Â | 1 | Â | Â | Â | Â | Â | Â | 2 |
Family history of disease | Â | Â | Â | Â | Â | Â | Â | Â | 1 | Â | Â | 1 | 2 |
Other blood products | Â | Â | Â | Â | Â | Â | 2 | Â | Â | Â | Â | Â | 2 |
Respiratory comorbidities | Â | Â | Â | Â | Â | Â | 1 | Â | Â | Â | Â | Â | 1 |
Liver comorbidities | Â | Â | Â | Â | 1 | Â | Â | Â | Â | Â | Â | Â | 1 |
Pre-operative transfusion | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 1 |
Age of blood transfused | Â | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 1 |
Septic shock | Â | Â | Â | Â | 1 | Â | Â | Â | Â | Â | Â | Â | 1 |
Total | 30 | 3 | 7 | 5 | 18 | 8 | 29 | 9 | 28 | 4 | 4 | 22 | 167 |